Zohar Dotan

7.1k citations
128 papers · 5.4k indexed · 3 hit papers · h-index 23

Impact in

Papers in

    • Urological Disorders and Treatments 17
    • Prostate Cancer Diagnosis and Treatment 28
    • Renal cell carcinoma treatment 24
    • Prostate Cancer Treatment and Research 22
    • Kidney Stones and Urolithiasis Treatments 12

Zohar Dotan

116 papers receiving 5.3k citations

Hit Papers

Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis 2005 · 1.5k citations
1.5k200320262010201850010001.5k

Peers

Zohar Dotan
Comparison fields: 5 of 119
  • Pulmonary and Respiratory Medicine 2.6k
  • Cancer Research 899
  • Urology 333
  • Oncology 1.0k
  • Aging 59
Replace Gennady Bratslavsky with:
Gennady Bratslavsky United States
David Y.T. Chen United States
A. Ari Hakimi United States
Marc‐Oliver Grimm Germany
Tamara L. Lotan United States
Junqi Qian United States
Stephan Störkel Germany
Mark N. Stein United States
Elai Davicioni United States
J E Tomaszewski United States
Zohar Dotan relative to Gennady Bratslavsky United States Gennady Bratslavsky's profile →
Citations per field
00.5×9.8×
Gennady Bratslavsky · 1×
Citations per year

Countries citing papers authored by Zohar Dotan

Since Specialization
Citations

This map shows the geographic impact of Zohar Dotan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zohar Dotan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zohar Dotan more than expected).

Fields of papers citing papers by Zohar Dotan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zohar Dotan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zohar Dotan. The network helps show where Zohar Dotan may publish in the future.

Co-authors

The 25 scholars most cited alongside Zohar Dotan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Zohar Dotan Line = papers co-authored together Zohar Dotan links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20250
3 20240
4 20233
5 20235
6 20230
7 202119
8 20200
9 202010
10 20203
11 20167
12 201617
13 201349
14 201323
15 201313
16 20124
17 201156
18
Preclinical evaluation of adoptive cell therapy for patients with metastatic renal cell carcinoma.
200933
19 2008125
20 20037

About Zohar Dotan

Zohar Dotan is a scholar working on Urology, Pulmonary and Respiratory Medicine, Obstetrics and Gynecology, Surgery and Rheumatology, having authored 128 papers that have together received 5.4k indexed citations. Recurring topics across this work include Prostate Cancer Diagnosis and Treatment (28 papers), Renal cell carcinoma treatment (24 papers), Bladder and Urothelial Cancer Treatments (23 papers), Prostate Cancer Treatment and Research (22 papers), Urinary and Genital Oncology Studies (19 papers), Urological Disorders and Treatments (17 papers), Renal and related cancers (15 papers) and Kidney Stones and Urolithiasis Treatments (12 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (2.6k citations), Cancer Research (899 citations), Urology (333 citations), Oncology (1.0k citations) and Aging (59 citations). Zohar Dotan has collaborated with scholars based in Israel, United States and Canada. Frequent co-authors include Fernando J. Bianco, James A. Eastham, Peter T. Scardino, Michael W. Kattan, Andrew J. Stephenson, Masaru Niki, Pier Paolo Pandolfi, Carlos Cordon‐Cardo, Jason A. Koutcher and Lloyd C. Trotman. Their work appears in journals such as The Journal of Urology, Journal of Clinical Oncology, Scientific Reports, Journal of Personalized Medicine and Urologic Oncology Seminars and Original Investigations.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026